APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2
APOE 在衰老大脑和 AD 中精心设计的分子特征——APOE2 的贡献
基本信息
- 批准号:10450775
- 负责人:
- 金额:$ 63.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:ATP-Binding Cassette TransportersAcuteAdrenal GlandsAffectAffinityAgingAllelesAlzheimer&aposs DiseaseAmyloid beta-ProteinAmyloid depositionApolipoprotein EAstrocytesAutophagocytosisAutopsyBindingBiological MarkersBiologyBrainCardiovascular DiseasesCell physiologyCholesterolChromosome 19CodeCognitionCognitive deficitsDataDiseaseEarly DiagnosisEpigenetic ProcessExhibitsGene ClusterGene ExpressionGene Expression ProfileGenesGenotypeGoalsHigh Density LipoproteinsHistonesHomeostasisHumanHuman PathologyHypolipoproteinemiaImmunologic ReceptorsImpaired cognitionImpairmentInflammationInjectionsInterventionLate Onset Alzheimer DiseaseLipidsLipoproteinsLow Density Lipoprotein ReceptorLow-Density LipoproteinsMammalian CellMediatingMetabolicMicrogliaMitochondriaMolecularMolecular ProfilingMolecular TargetMusNerve DegenerationNetwork-basedNeurogliaNeuronsPathogenesisPathologicPatientsPhagocytosisPhenotypePhospholipidsPhysiologyPopulationProcessProtein IsoformsRegulationReportingResearchRiskRoleSamplingSignal TransductionSurfaceTechnologyTestingTweensVery low density lipoproteinage effectage relatedaging brainapolipoprotein E-4basebrain cellcell typecognitive performancedifferential expressionepigenomegene networkgenetic risk factorhigh riskimmune functionlipidomelipidomicsmind controlnext generation sequencingnovel therapeutic interventionparticlepreventprotective effectprotein degradationreceptor bindingtranscriptometranscriptomicsuptake
项目摘要
The inheritance of APOEε4 allele is the strongest genetic risk factor for late onset Alzheimer’s disease (LOAD).
In fact, the inheritance of APOEε4 allele is the strongest known genetic risk factor in human pathology, but the
mechanism is poorly understood. In contrast, APOEε2 allele is protective for AD and age-related diseases AD.
While APOE has been associated with critical cellular functions such as oxidative processes, inflammation, glial
cell and neuronal homeostasis, none of those can be dissociated from binding, transport and delivery of choles-
terol and phospholipids to different cell types by APOE containing lipoprotein particles. It is also uniformly ac-
cepted that the above functions are APOE-isoform specific. Our preliminary data demonstrates that phospholipid
composition of APOEε3/3 and APOEε4/4 AD brain differs significantly. Most prominent were changes in lipid
classes that are critical in regulation of normal mitochondrial function and dynamics, but also in execution of
metabolic cascades part of regulated intracellular protein degradation known as autophagy and mitophagy. We
also found significant APOE isoform-specific differences between the transcriptomic profiles of the AD samples
that substantiate molecular explanation of specific AD pathological changes in brain, based on perturbed gene
expression. Our preliminary data also demonstrates that there is a significant difference in the phospholipid
content of native APOE2, APOE3- and APOE4- lipoproteins suggesting that that they may affect differentially
surface immune receptors and initiate different signal transduction cascades.
We hypothesize that the APOE isoform-specific effects on phenotype are driven by the different phospholipid
composition of APOE lipid particles and/or by the differential effect of APOE isoforms on brain transcriptome and
lipidome. In the First SA, we will establish the association of APOE alleles with AD brain transcriptome and
lipidome and determine the allele specific impact on mitochondrial function and dynamics. We will use postmor-
tem brain samples from AD patients and controls of different APOE genotypes to determine differences in tran-
scriptomes and lipidomes within and between genotypes. We will generate and analyze correlated/co-expressed
gene networks based on APOE allele associated differentially expressed genes and perform correlation analyses
to identify associations between genes and lipids in brain. In the Second SA, we will investigate APOE isoform-
dependent epigenetic and transcriptomic changes in AD brain and APOE Targeted Replacement mice. We will
determine the enrichment of histone marks in specific cell types isolated from human AD and control brains
and will examine APOE allele specific correlations to gene expression profiles. Next, we will examine the
effect of aging on epigenome and transcriptome in distinct brain cell types of human APOE TR mice. In the
Third SA, we will determine how APOE2 lipoproteins counteract the acute deleterious effects of A. The goals
are to examine the effect of APOE2, E3 and E4 lipoproteins on: transcriptome of distinct brain cell populations
and cognition in mice following intracranial injection of A
载脂蛋白Eε4等位基因的遗传是晚发性阿尔茨海默病(LOAD)最强的遗传危险因素。
事实上,载脂蛋白Eε4等位基因的遗传是人类病理中已知的最强的遗传风险因素,但
机制还不是很清楚。相反,载脂蛋白Eε2等位基因对AD和老年性疾病AD具有保护作用。
虽然载脂蛋白E与氧化过程等关键细胞功能有关,但在fl氨基酸中,胶质细胞
细胞和神经元的动态平衡,这些都不能从胆碱的结合、运输和输送中分离出来。
通过含脂蛋白颗粒的载脂蛋白对不同细胞类型的Terol和磷脂进行ff分析。它也是统一的AC-
我们的初步数据表明,这些功能是apoe-fic的异构体。
载脂蛋白ε3/3和载脂蛋白ε4/4 AD脑的组成有显著差异。最突出的是血脂的变化。
在正常线粒体功能和动力学的调节中至关重要的类,但在执行
代谢级联作用是调节细胞内蛋白质降解的一部分,称为自噬和有丝分裂。我们
还发现AD样本的转录图谱之间存在显著的APOE亚型特异性差异
证实了基于扰动基因的脑内特定AD病理变化的分子解释
表情。我们的初步数据也表明,在磷脂中有显著的差异
天然载脂蛋白2、载脂蛋白3和载脂蛋白4的含量表明它们可能对
表面免疫受体,并启动不同的信号转导级联。
我们假设APOE异构体fi对表型的影响是由不同的磷脂驱动的
载脂蛋白脂质颗粒的组成和/或载脂蛋白亚型在脑转录组和/或脑转录组上的差异ff等
脂质体。在第一个SA中,我们将建立载脂蛋白E等位基因与AD脑转录组和
并确定等位基因对线粒体功能和动力学的特异性影响。我们将使用邮局-
不同载脂蛋白E基因携带者与AD患者及对照组的脑组织标本比较
基因内和基因间的手稿和脂体。我们将生成并分析相关/共同表达
基于APOE等位基因相关差异表达基因的基因网络及其相关性分析
以确定大脑中基因和血脂之间的联系。在第二个SA中,我们将研究APOE亚型-
AD脑和APOE靶向替换小鼠的依赖表观遗传学和转录改变。我们会
从人类AD和对照脑组织分离的特定细胞类型中确定组蛋白标记的富集度
并将检查APOE等位基因与基因表达谱的特定相关性。接下来,我们将研究
衰老对不同脑细胞类型的apoe-tr小鼠表观基因组和转录组的影响。在
第三,SA,我们将确定载脂蛋白2脂蛋白如何抵消A的急性有害影响。目标
是为了研究APOE2、E3和E4脂蛋白对不同脑细胞群体转录组的影响
脑内注射对小鼠认知功能的影响
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RADOSVETA KOLDAMOVA其他文献
RADOSVETA KOLDAMOVA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RADOSVETA KOLDAMOVA', 18)}}的其他基金
The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
Tau 和 ncRNA 之间的相互作用 — 早期 AD 发病机制的基因组和表观基因组线索
- 批准号:
10447273 - 财政年份:2022
- 资助金额:
$ 63.59万 - 项目类别:
The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
Tau 和 ncRNA 之间的相互作用 — 早期 AD 发病机制的基因组和表观基因组线索
- 批准号:
10634661 - 财政年份:2022
- 资助金额:
$ 63.59万 - 项目类别:
ncRNAs in plasma EVs of AD patients and their discriminatory power as biomarkers
AD 患者血浆 EV 中的 ncRNA 及其作为生物标志物的区分能力
- 批准号:
10532000 - 财政年份:2022
- 资助金额:
$ 63.59万 - 项目类别:
APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2
APOE 在衰老大脑和 AD 中精心设计的分子特征——APOE2 的贡献
- 批准号:
10170188 - 财政年份:2018
- 资助金额:
$ 63.59万 - 项目类别:
APOE orchestrated ''molecular signatures'' in aging brain and AD - the contribution of APOE2
APOE 在衰老大脑和 AD 中精心策划了“分子特征”——APOE2 的贡献
- 批准号:
9555298 - 财政年份:2017
- 资助金额:
$ 63.59万 - 项目类别:
Epigenetic and phenotypic effects of arsenic: impacts on cognition and AD
砷的表观遗传和表型效应:对认知和 AD 的影响
- 批准号:
8755745 - 财政年份:2014
- 资助金额:
$ 63.59万 - 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
- 批准号:
8103681 - 财政年份:2011
- 资助金额:
$ 63.59万 - 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
- 批准号:
8484324 - 财政年份:2011
- 资助金额:
$ 63.59万 - 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
- 批准号:
8277207 - 财政年份:2011
- 资助金额:
$ 63.59万 - 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
- 批准号:
8850760 - 财政年份:2011
- 资助金额:
$ 63.59万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 63.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 63.59万 - 项目类别:
Operating Grants














{{item.name}}会员




